METHYLENE BLUE

METHYLENE BLUE was reported 1578 times

METHYLENE BLUE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 LYMPHATIC MAPPING 1 0.2500
1 KORSAKOFF'S PSYCHOSIS ALCOHOLIC 1 0.2500
2 MYOGLOBIN URINE PRESENT 60 0.2439
3 PHYSICAL THYROID EXAMINATION ABNORMAL 1 0.1667
4 TISSUE DISCOLOURATION 6 0.1053
5 VASCULAR RESISTANCE PULMONARY INCREASED 8 0.0930
6 URETHRAL STRICTURE POSTOPERATIVE 1 0.0667
7 TESTICULAR INJURY 2 0.0476
8 ACQUIRED METHAEMOGLOBINAEMIA 2 0.0455
9 VASOPLEGIA SYNDROME 71 0.0433
10 HARLEQUIN SYNDROME 3 0.0411
11 BLOOD METHAEMOGLOBIN PRESENT 4 0.0360
12 SEDATIVE THERAPY 2 0.0351
13 OSMOLAR GAP 2 0.0323
14 HYPERDYNAMIC LEFT VENTRICLE 7 0.0285
15 TURBINECTOMY 1 0.0263
16 METHAEMOGLOBINAEMIA 60 0.0259
17 SEROTONIN SYNDROME 469 0.0244
18 ELECTROCARDIOGRAM ST-T SEGMENT ELEVATION 1 0.0233
19 CARDIAC INDEX INCREASED 1 0.0227
20 HEPATIC ISCHAEMIA 7 0.0225
21 HAEMODILUTION 2 0.0202
22 MENTAL STATUS CHANGES POSTOPERATIVE 2 0.0189
23 DISTRIBUTIVE SHOCK 41 0.0181
24 STAPHYLOCOCCAL IMPETIGO 1 0.0175
25 AMYLASE INCREASED 60 0.0162
26 BURKHOLDERIA TEST POSITIVE 2 0.0161
27 CYANOSIS CENTRAL 4 0.0154
28 CONFUSION POSTOPERATIVE 2 0.0153
29 BARTONELLOSIS 1 0.0152
30 TOXIC ENCEPHALOPATHY 76 0.0150
31 ANAESTHETIC COMPLICATION CARDIAC 1 0.0145
32 MEAN ARTERIAL PRESSURE INCREASED 1 0.0143
33 INFECTED SEROMA 1 0.0139
34 PERIRENAL HAEMATOMA 3 0.0138
35 GLASGOW COMA SCALE ABNORMAL 5 0.0136
36 CLONUS 37 0.0135
37 CARDIAC CONTRACTILITY DECREASED 1 0.0130
38 DELAYED RECOVERY FROM ANAESTHESIA 12 0.0127
39 CARDIAC FAILURE HIGH OUTPUT 3 0.0124
40 BLOOD LACTIC ACID DECREASED 2 0.0116
41 JAUNDICE ACHOLURIC 1 0.0114
42 HERBAL INTERACTION 4 0.0110
43 SCLEROSING ENCAPSULATING PERITONITIS 2 0.0109
44 LINEAR IGA DISEASE 18 0.0108
45 LABELLED DRUG-DISEASE INTERACTION ISSUE 1 0.0105
46 ALKALOSIS 4 0.0105
47 POSTOPERATIVE THORACIC PROCEDURE COMPLICATION 1 0.0103
48 LABORATORY TEST INTERFERENCE 8 0.0102
49 BLOOD ERYTHROPOIETIN INCREASED 1 0.0101
50 RIGHT ATRIAL ENLARGEMENT 2 0.0101
51 HYPERREFLEXIA 35 0.0100
52 IMAGING PROCEDURE ABNORMAL 1 0.0100
53 JARISCH-HERXHEIMER REACTION 7 0.0098
54 EAR DRYNESS 1 0.0095
55 PHAEOCHROMOCYTOMA CRISIS 2 0.0094
56 PERITONEAL ABSCESS 2 0.0094
57 ABDOMINAL COMPARTMENT SYNDROME 6 0.0094
58 OPSOCLONUS MYOCLONUS 2 0.0094
59 SULPHAEMOGLOBINAEMIA 1 0.0086
60 NON-CARDIOGENIC PULMONARY OEDEMA 9 0.0085
61 COMA SCALE ABNORMAL 23 0.0079
62 MEAN ARTERIAL PRESSURE DECREASED 2 0.0079
63 ANION GAP 5 0.0079
64 TROPONIN INCREASED 60 0.0079
65 PASTEURELLA INFECTION 1 0.0078
66 COMPARTMENT SYNDROME 20 0.0077
67 EXTENSOR PLANTAR RESPONSE 7 0.0076
68 VASCULAR RESISTANCE SYSTEMIC DECREASED 1 0.0075
69 AIRWAY PEAK PRESSURE INCREASED 1 0.0066
70 RED BLOOD CELL MORPHOLOGY ABNORMAL 1 0.0065
71 PARASPINAL ABSCESS 1 0.0065
72 LYMPHORRHOEA 1 0.0064
73 GALLBLADDER NECROSIS 1 0.0063
74 BACTERIAL TRANSLOCATION 2 0.0063
75 BLINDNESS CORTICAL 3 0.0061
76 LOW CARDIAC OUTPUT SYNDROME 2 0.0060
77 PNEUMONITIS ASPIRATION 2 0.0058
78 REACTION TO AZO-DYES 1 0.0058
79 ATHETOSIS 1 0.0057
80 NYSTAGMUS 30 0.0056
81 ANTICHOLINERGIC SYNDROME 9 0.0056
82 PELVIC PROLAPSE 1 0.0056
83 VASOSPASM 5 0.0054
84 PERSEVERATION 1 0.0054
85 ELECTROCARDIOGRAM QRS COMPLEX SHORTENED 2 0.0052
86 BREAST OEDEMA 1 0.0052
87 DEAFNESS PERMANENT 1 0.0051
88 SYSTEMIC TOXICITY 1 0.0049
89 PUPILLARY REFLEX IMPAIRED 9 0.0049
90 SHIFT TO THE LEFT 1 0.0049
91 HISTAMINE LEVEL INCREASED 1 0.0046
92 DRUG CLEARANCE DECREASED 6 0.0046
93 DISSEMINATED STRONGYLOIDIASIS 1 0.0046
94 PSEUDOMONAL SEPSIS 8 0.0046
95 PULSE ABSENT 21 0.0044
96 GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY 1 0.0043
97 TUMOUR ULCERATION 1 0.0042
98 ACUTE LUNG INJURY 5 0.0042
99 CALCIUM IONISED DECREASED 1 0.0041
100 PARATHYROID TUMOUR BENIGN 3 0.0040
101 MULTIPLE DRUG THERAPY 3 0.0040
102 VASCULAR ACCESS SITE COMPLICATION 1 0.0040
103 RETINAL TOXICITY 4 0.0039
104 BLOOD POTASSIUM INCREASED 62 0.0038
105 BLOOD LACTATE DEHYDROGENASE INCREASED 60 0.0038
106 OPISTHOTONUS 3 0.0038
107 PULMONARY HYPERTENSIVE CRISIS 1 0.0037
108 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 8 0.0036
109 DRUG LEVEL BELOW THERAPEUTIC 20 0.0036
110 CARDIAC SEPTAL HYPERTROPHY 1 0.0036
111 POSTOPERATIVE FEVER 1 0.0036
112 REPETITIVE SPEECH 2 0.0036
113 CARDIOGENIC SHOCK 51 0.0036
114 APPENDICITIS PERFORATED 9 0.0035
115 NODAL ARRHYTHMIA 3 0.0035
116 LENS DISORDER 1 0.0035
117 RIGHT VENTRICULAR DILATATION 2 0.0035
118 INTESTINAL PSEUDO-OBSTRUCTION 3 0.0034
119 HEART FAILURE WITH PRESERVED EJECTION FRACTION 1 0.0034
120 ENCEPHALOPATHY 82 0.0033
121 POLYCHROMASIA 1 0.0033
122 ENTEROBACTER BACTERAEMIA 1 0.0033
123 MYDRIASIS 41 0.0032
124 URINE CALCIUM INCREASED 1 0.0032
125 ALOPECIA TOTALIS 1 0.0030
126 PNEUMONIA ESCHERICHIA 1 0.0029
127 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 15 0.0029
128 LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION 1 0.0029
129 RADIOISOTOPE SCAN ABNORMAL 2 0.0028
130 SHOCK 65 0.0028
131 PCO2 INCREASED 2 0.0028
132 HAEMOLYTIC ANAEMIA 25 0.0028
133 AMNIOTIC CAVITY INFECTION 2 0.0028
134 HAEMODYNAMIC INSTABILITY 21 0.0028
135 HYPERPARATHYROIDISM PRIMARY 1 0.0027
136 THERAPEUTIC PRODUCT EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0027
137 HYPERTHERMIA MALIGNANT 4 0.0027
138 MEDIASTINAL DISORDER 1 0.0027
139 HEART SOUNDS ABNORMAL 2 0.0027
140 INTENSIVE CARE UNIT ACQUIRED WEAKNESS 1 0.0026
141 HYPERTHERMIA 20 0.0026
142 PO2 DECREASED 3 0.0026
143 OSTEOSARCOMA 1 0.0026
144 INHIBITORY DRUG INTERACTION 4 0.0025
145 BLOOD CREATINE PHOSPHOKINASE INCREASED 72 0.0025
146 LYMPHANGITIS 2 0.0025
147 DISINHIBITION 4 0.0025
148 HYPERTONIA 14 0.0024
149 PULSELESS ELECTRICAL ACTIVITY 10 0.0024
150 PYRAMIDAL TRACT SYNDROME 1 0.0024
151 MUSCLE RIGIDITY 28 0.0023
152 CITROBACTER INFECTION 1 0.0023
153 PUPIL FIXED 4 0.0023
154 DRUG INTERACTION 358 0.0023
155 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 6 0.0023
156 LOCALISED INTRAABDOMINAL FLUID COLLECTION 1 0.0022
157 BLOOD CREATINE PHOSPHOKINASE ABNORMAL 1 0.0022
158 PANCREATITIS HAEMORRHAGIC 1 0.0022
159 HYPERPYREXIA 9 0.0021
160 PARATHYROIDECTOMY 1 0.0021
161 NOROVIRUS INFECTION 3 0.0021
162 DIABETES INSIPIDUS 5 0.0021
163 STARING 5 0.0021
164 PO2 INCREASED 1 0.0020
165 INJECTION SITE NECROSIS 4 0.0020
166 ACIDOSIS 15 0.0020
167 METASTATIC SQUAMOUS CELL CARCINOMA 1 0.0020
168 OLIGURIA 12 0.0019
169 POSTURING 1 0.0019
170 PLASMAPHERESIS 1 0.0019
171 HYPOPERFUSION 2 0.0019
172 SYSTOLIC DYSFUNCTION 2 0.0019
173 NEUROMYOPATHY 2 0.0019
174 ALBUMINURIA 1 0.0019
175 HYPERLACTACIDAEMIA 5 0.0019
176 HEPATIC NECROSIS 7 0.0019
177 LACTIC ACIDOSIS 60 0.0019
178 TOXIC ANTERIOR SEGMENT SYNDROME 2 0.0018
179 BLOOD PHOSPHORUS INCREASED 5 0.0018
180 HYPERVOLAEMIA 9 0.0018
181 BRAIN SCAN ABNORMAL 1 0.0018
182 ILEUS 22 0.0018
183 URINE COLOUR ABNORMAL 1 0.0018
184 NEUROLOGICAL DECOMPENSATION 4 0.0017
185 METAL POISONING 1 0.0017
186 THERAPEUTIC PRODUCT EFFECT INCREASED 2 0.0017
187 CRYSTAL NEPHROPATHY 1 0.0017
188 MULTIPLE ORGAN DYSFUNCTION SYNDROME 47 0.0017
189 OXYGEN CONSUMPTION DECREASED 1 0.0017
190 INTESTINAL ISCHAEMIA 9 0.0016
191 NIPPLE DISORDER 1 0.0016
192 INTENTIONAL OVERDOSE 100 0.0016
193 INTRACRANIAL HYPOTENSION 1 0.0015
194 METABOLIC ACIDOSIS 49 0.0015
195 RESPIRATORY ACIDOSIS 6 0.0015
196 PHAEOCHROMOCYTOMA 1 0.0015
197 CHROMATURIA 34 0.0015
198 ANION GAP INCREASED 2 0.0015
199 POST PROCEDURAL DISCHARGE 1 0.0015
200 SOFT TISSUE NECROSIS 1 0.0015
201 HYPERPARATHYROIDISM 3 0.0015
202 SUTURE RUPTURE 1 0.0014
203 NUTRITIONAL CONDITION ABNORMAL 1 0.0014
204 SUSPICIOUSNESS 1 0.0014
205 RENAL TUBULAR DISORDER 4 0.0014
206 MALARIA 1 0.0014
207 FANCONI SYNDROME 2 0.0014
208 EYE ROLLING 1 0.0014
209 SMALL FOR DATES BABY 7 0.0014
210 TRYPTASE INCREASED 1 0.0014
211 TRACHEOSTOMY 2 0.0014
212 OCULOGYRIC CRISIS 3 0.0014
213 RESPIRATORY DEPRESSION 17 0.0014
214 MUTISM 2 0.0014
215 CLONIC CONVULSION 1 0.0014
216 AMPHETAMINES POSITIVE 1 0.0013
217 GASTROINTESTINAL HYPOMOTILITY 3 0.0013
218 BLOOD LACTIC ACID INCREASED 7 0.0013
219 VEIN COLLAPSE 1 0.0013
220 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 2 0.0012
221 VENTRICULAR HYPOKINESIA 4 0.0012
222 STRONGYLOIDIASIS 2 0.0012
223 CIRCULATORY COLLAPSE 21 0.0012
224 SPUTUM CULTURE POSITIVE 1 0.0012
225 PULMONARY ARTERIAL PRESSURE INCREASED 2 0.0012
226 PSEUDOMONAS TEST POSITIVE 1 0.0012
227 COMA 58 0.0012
228 LEUKOCYTURIA 1 0.0012
229 HYPERNATRAEMIA 6 0.0012
230 LYME DISEASE 4 0.0012
231 PROCEDURAL HYPOTENSION 1 0.0012
232 GAZE PALSY 2 0.0012
233 TONGUE MOVEMENT DISTURBANCE 1 0.0012
234 BRADYCARDIA 62 0.0012
235 HAEMOLYSIS 9 0.0012
236 CHOREA 2 0.0012
237 TREATMENT DELAYED 2 0.0012
238 CYSTOCELE 1 0.0012
239 TRANSFUSION REACTION 1 0.0011
240 INFUSION SITE DISCOLOURATION 1 0.0011
241 ABDOMINAL SEPSIS 1 0.0011
242 ENTEROCUTANEOUS FISTULA 1 0.0011
243 RENAL TUBULAR ATROPHY 1 0.0011
244 CARDIAC OUTPUT DECREASED 1 0.0011
245 BRADYPNOEA 3 0.0011
246 INCISION SITE INFECTION 1 0.0011
247 VENTRICULAR ARRHYTHMIA 4 0.0011
248 ALANINE AMINOTRANSFERASE INCREASED 67 0.0011
249 ISCHAEMIA 5 0.0011
250 SKIN TEST POSITIVE 1 0.0011
251 ENDOTRACHEAL INTUBATION 3 0.0011
252 BUNDLE BRANCH BLOCK 1 0.0011
253 STEREOTYPY 1 0.0011
254 OXYGEN SATURATION ABNORMAL 3 0.0011
255 PNEUMATOSIS INTESTINALIS 3 0.0011
256 COMMUNICATION DISORDER 4 0.0010
257 PYELOCALIECTASIS 1 0.0010
258 HYPOREFLEXIA 2 0.0010
259 DISCOLOURED VOMIT 1 0.0010
260 HYPOTENSION 208 0.0010
261 MATERNAL EXPOSURE DURING DELIVERY 1 0.0010
262 MYOCLONUS 12 0.0010
263 ADMINISTRATION SITE EXTRAVASATION 1 0.0010
264 HYPERCAPNIA 3 0.0010
265 BRAIN HYPOXIA 1 0.0010
266 FALSE POSITIVE INVESTIGATION RESULT 1 0.0010
267 HYPOTHERMIA 10 0.0010
268 DEPRESSED LEVEL OF CONSCIOUSNESS 39 0.0010
269 RHABDOMYOLYSIS 41 0.0010
270 BRAIN STEM INFARCTION 1 0.0010
271 MENTAL STATUS CHANGES 27 0.0010
272 BRAIN DEATH 3 0.0010
273 TRISMUS 5 0.0010
274 GENERALISED TONIC-CLONIC SEIZURE 16 0.0010
275 SKIN NECROSIS 5 0.0010
276 POSTICTAL STATE 1 0.0010
277 LIVEDO RETICULARIS 2 0.0010
278 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 52 0.0009
279 IMMEDIATE POST-INJECTION REACTION 1 0.0009
280 RIGHT VENTRICULAR DYSFUNCTION 1 0.0009
281 CLOSTRIDIUM TEST POSITIVE 2 0.0009
282 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 3 0.0009
283 CORNEAL OEDEMA 2 0.0009
284 GASTROINTESTINAL BACTERIAL INFECTION 1 0.0009
285 PUPILS UNEQUAL 1 0.0009
286 BUNDLE BRANCH BLOCK RIGHT 4 0.0009
287 AORTIC THROMBOSIS 1 0.0009
288 ACUTE RESPIRATORY DISTRESS SYNDROME 15 0.0008
289 PRODUCT CONTAMINATION MICROBIAL 1 0.0008
290 TOXICITY TO VARIOUS AGENTS 141 0.0008
291 AGITATION 61 0.0008
292 HYPERKALAEMIA 29 0.0008
293 NEUROTOXICITY 14 0.0008
294 BRAIN INJURY 8 0.0008
295 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 1 0.0008
296 VASODILATATION 2 0.0008
297 DELIRIUM 27 0.0008
298 SINUS TACHYCARDIA 11 0.0008
299 TONIC CLONIC MOVEMENTS 1 0.0008
300 TUMOUR PAIN 1 0.0008
301 ANAESTHETIC COMPLICATION 2 0.0007
302 COLITIS ISCHAEMIC 5 0.0007
303 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 1 0.0007
304 GLYCOSURIA 1 0.0007
305 CARBON DIOXIDE INCREASED 1 0.0007
306 ISCHAEMIC HEPATITIS 1 0.0007
307 EYE MOVEMENT DISORDER 5 0.0007
308 INFUSION SITE RASH 1 0.0007
309 ANAPHYLACTOID REACTION 3 0.0007
310 VIRAEMIA 1 0.0007
311 NECROSIS 4 0.0007
312 LEUKOCYTOSIS 13 0.0007
313 CARDIAC ARREST 59 0.0007
314 H1N1 INFLUENZA 1 0.0007
315 BUNDLE BRANCH BLOCK LEFT 3 0.0007
316 FEBRILE BONE MARROW APLASIA 3 0.0007
317 AUDITORY DISORDER 1 0.0007
318 POST HERPETIC NEURALGIA 1 0.0007
319 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 1 0.0007
320 GASTROINTESTINAL NECROSIS 2 0.0007
321 AUTONOMIC NERVOUS SYSTEM IMBALANCE 2 0.0007
322 RED BLOOD CELL COUNT ABNORMAL 1 0.0007
323 POST PROCEDURAL COMPLICATION 13 0.0007
324 BLOOD PARATHYROID HORMONE DECREASED 1 0.0007
325 GASTROINTESTINAL WALL THICKENING 1 0.0007
326 DRUG TOXICITY 9 0.0007
327 IMMUNE THROMBOCYTOPENIA 3 0.0007
328 CONTRAINDICATION TO MEDICAL TREATMENT 1 0.0007
329 HYPOXIA 23 0.0007
330 PROCEDURAL COMPLICATION 5 0.0007
331 GASTROSTOMY 1 0.0006
332 HYPOVOLAEMIC SHOCK 3 0.0006
333 NEPHROPATHY TOXIC 7 0.0006
334 ENTEROCOCCAL INFECTION 3 0.0006
335 UNRESPONSIVE TO STIMULI 16 0.0006
336 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 2 0.0006
337 IGA NEPHROPATHY 1 0.0006
338 PLANTAR FASCIITIS 2 0.0006
339 APHASIA 18 0.0006
340 POTENTIATING DRUG INTERACTION 2 0.0006
341 WRONG PRODUCT ADMINISTERED 4 0.0006
342 SEIZURE LIKE PHENOMENA 1 0.0006
343 KIDNEY FIBROSIS 1 0.0006
344 ALOPECIA AREATA 1 0.0006
345 FANCONI SYNDROME ACQUIRED 1 0.0006
346 HANGOVER 2 0.0006
347 DYSKINESIA 23 0.0006
348 CARDIOTOXICITY 5 0.0006
349 CONTRAST MEDIA ALLERGY 1 0.0005
350 SUICIDE ATTEMPT 33 0.0005
351 ABORTION INCOMPLETE 1 0.0005
352 MECHANICAL VENTILATION 1 0.0005
353 HYPERCOAGULATION 1 0.0005
354 MUSCLE TWITCHING 12 0.0005
355 AUTOIMMUNE DISORDER 5 0.0005
356 APLASIA 1 0.0005
357 VOCAL CORD DISORDER 1 0.0005
358 DISORIENTATION 20 0.0005
359 ANORECTAL DISORDER 1 0.0005
360 ACUTE KIDNEY INJURY 76 0.0005
361 MUCOSAL DRYNESS 1 0.0005
362 SMALL INTESTINAL HAEMORRHAGE 1 0.0005
363 OVERDOSE 107 0.0005
364 PERIPHERAL ISCHAEMIA 2 0.0005
365 PARALYSIS 7 0.0005
366 INFUSION SITE EXTRAVASATION 3 0.0005
367 SKIN DISCOLOURATION 22 0.0005
368 LUNG ABSCESS 1 0.0005
369 ANAPHYLACTIC REACTION 26 0.0005
370 ANAPHYLACTIC SHOCK 12 0.0005
371 LANGUAGE DISORDER 1 0.0005
372 ASPIRATION 5 0.0005
373 CONFUSIONAL STATE 72 0.0004
374 THERAPY NON-RESPONDER 20 0.0004
375 FEAR OF DEATH 1 0.0004
376 TACHYPNOEA 6 0.0004
377 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 1 0.0004
378 DISSEMINATED INTRAVASCULAR COAGULATION 6 0.0004
379 CONTRAST MEDIA REACTION 1 0.0004
380 PSYCHOMOTOR HYPERACTIVITY 7 0.0004
381 EOSINOPHIL COUNT DECREASED 1 0.0004
382 KIDNEY TRANSPLANT REJECTION 2 0.0004
383 FAECAL INCONTINENCE 2 0.0004
384 LOWER GASTROINTESTINAL HAEMORRHAGE 3 0.0004
385 TACHYCARDIA 36 0.0004
386 GENERALISED OEDEMA 5 0.0004
387 BLOOD IMMUNOGLOBULIN G DECREASED 1 0.0004
388 DEVICE INFUSION ISSUE 1 0.0004
389 PNEUMONIA ASPIRATION 10 0.0004
390 EOSINOPHILIA 7 0.0004
391 BLOOD CREATININE INCREASED 26 0.0004
392 POISONING 5 0.0004
393 CHEMICAL BURN OF SKIN 1 0.0004
394 VENTRICULAR DYSFUNCTION 1 0.0004
395 RESTLESSNESS 14 0.0004
396 PSYCHOMOTOR SKILLS IMPAIRED 1 0.0004
397 CYANOSIS 6 0.0004
398 EXFOLIATIVE RASH 1 0.0004
399 LUNG OPACITY 1 0.0004
400 TYPE IV HYPERSENSITIVITY REACTION 1 0.0004
401 FAECALOMA 2 0.0004
402 VENTRICULAR TACHYCARDIA 6 0.0004
403 PHOTOSENSITIVITY REACTION 6 0.0004
404 ACUTE CORONARY SYNDROME 3 0.0004
405 ELECTROCARDIOGRAM QT PROLONGED 13 0.0004
406 THERAPEUTIC RESPONSE DELAYED 1 0.0004
407 PULMONARY OEDEMA 16 0.0004
408 PROCTITIS 1 0.0004
409 PSYCHOMOTOR RETARDATION 1 0.0004
410 STATUS EPILEPTICUS 4 0.0004
411 NEUROLOGICAL SYMPTOM 2 0.0003
412 VENTRICULAR SEPTAL DEFECT 2 0.0003
413 STRESS CARDIOMYOPATHY 2 0.0003
414 BLOOD PARATHYROID HORMONE INCREASED 1 0.0003
415 PRODUCT LABEL CONFUSION 2 0.0003
416 URINE OUTPUT DECREASED 3 0.0003
417 BODY TEMPERATURE INCREASED 7 0.0003
418 BLOOD CALCIUM INCREASED 3 0.0003
419 HYPOVOLAEMIA 2 0.0003
420 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 3 0.0003
421 ENERGY INCREASED 2 0.0003
422 METABOLIC ENCEPHALOPATHY 1 0.0003
423 NORMOCHROMIC NORMOCYTIC ANAEMIA 1 0.0003
424 MYELOFIBROSIS 1 0.0003
425 RESTLESS LEGS SYNDROME 6 0.0003
426 TOXIC EPIDERMAL NECROLYSIS 5 0.0003
427 GRAND MAL CONVULSION 3 0.0003
428 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 2 0.0003
429 ERYTHEMA MULTIFORME 3 0.0003
430 RESPIRATORY RATE DECREASED 1 0.0003
431 ELECTROENCEPHALOGRAM ABNORMAL 1 0.0003
432 BREAST CANCER RECURRENT 1 0.0003
433 INCOHERENT 2 0.0003
434 HYPOVENTILATION 1 0.0003
435 RENAL TUBULAR NECROSIS 3 0.0003
436 THROMBOSIS IN DEVICE 1 0.0003
437 INFUSION SITE HAEMORRHAGE 1 0.0003
438 SALIVARY HYPERSECRETION 3 0.0003
439 ATRIOVENTRICULAR BLOCK COMPLETE 2 0.0003
440 CONTRAINDICATED PRODUCT ADMINISTERED 9 0.0003
441 INTENTIONAL SELF-INJURY 6 0.0003
442 BK VIRUS INFECTION 1 0.0003
443 WOUND DEHISCENCE 1 0.0003
444 LEFT VENTRICULAR FAILURE 1 0.0003
445 PRIAPISM 1 0.0003
446 RESPIRATORY DISTRESS 8 0.0003
447 MICTURITION DISORDER 1 0.0003
448 EXTRASYSTOLES 2 0.0003
449 RIGHT VENTRICULAR FAILURE 2 0.0003
450 PRODUCT CONTAMINATION 1 0.0003
451 SCLERODERMA 1 0.0003
452 RASH PUSTULAR 2 0.0003
453 THROMBOCYTOSIS 1 0.0003
454 HYPOPHOSPHATAEMIA 2 0.0003
455 CEREBRAL DISORDER 2 0.0003
456 NEURODERMATITIS 1 0.0003
457 BLOOD CALCIUM DECREASED 3 0.0003
458 HEPATIC FAILURE 8 0.0003
459 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 1 0.0003
460 WHITE BLOOD CELL COUNT INCREASED 10 0.0003
461 CHOLESTASIS 5 0.0003
462 FEAR 7 0.0003
463 ACUTE RESPIRATORY FAILURE 5 0.0003
464 THERAPEUTIC PRODUCT INEFFECTIVE 1 0.0003
465 PANIC DISORDER 1 0.0003
466 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 2 0.0003
467 EJECTION FRACTION DECREASED 4 0.0003
468 CARDIOPULMONARY FAILURE 1 0.0003
469 NERVOUS SYSTEM DISORDER 8 0.0003
470 TORSADE DE POINTES 2 0.0003
471 LOW BIRTH WEIGHT BABY 2 0.0003
472 TRANSPLANT REJECTION 2 0.0002
473 ARTERIOSPASM CORONARY 1 0.0002
474 ORGAN FAILURE 1 0.0002
475 FUNGAL SKIN INFECTION 1 0.0002
476 RECURRENT CANCER 1 0.0002
477 EXTRAVASATION 1 0.0002
478 ESCHERICHIA INFECTION 2 0.0002
479 APPLICATION SITE EXFOLIATION 1 0.0002
480 HEMIPLEGIA 2 0.0002
481 COAGULOPATHY 4 0.0002
482 PULMONARY HYPERTENSION 5 0.0002
483 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 7 0.0002
484 BLOOD UREA INCREASED 4 0.0002
485 HAEMODIALYSIS 2 0.0002
486 FACE OEDEMA 4 0.0002
487 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
488 CARDIAC FAILURE CHRONIC 1 0.0002
489 DRUG INEFFECTIVE 309 0.0002
490 LEFT VENTRICULAR HYPERTROPHY 1 0.0002
491 PSEUDOMONAS INFECTION 2 0.0002
492 INFUSION SITE PAIN 3 0.0002
493 OXYGEN SATURATION DECREASED 13 0.0002
494 FAECES DISCOLOURED 5 0.0002
495 SPEECH DISORDER 12 0.0002
496 TONGUE DISCOLOURATION 1 0.0002
497 PARONYCHIA 1 0.0002
498 PHYSICAL DISABILITY 1 0.0002
499 BLOOD CREATINE INCREASED 1 0.0002
500 ASPARTATE AMINOTRANSFERASE INCREASED 12 0.0002
501 HEPATOTOXICITY 5 0.0002
502 ANAL INCONTINENCE 2 0.0002
503 URINARY TRACT DISORDER 1 0.0002
504 VASCULAR DEVICE INFECTION 1 0.0002
505 AKATHISIA 3 0.0002
506 HYPERGLYCAEMIA 8 0.0002
507 PATHOGEN RESISTANCE 2 0.0002
508 RESPIRATORY FAILURE 16 0.0002
509 HYPOKALAEMIA 10 0.0002
510 SEIZURE 25 0.0002
511 LOCALISED OEDEMA 1 0.0002
512 PRODUCT DISTRIBUTION ISSUE 2 0.0002
513 HYPOMAGNESAEMIA 3 0.0002
514 COORDINATION ABNORMAL 3 0.0002
515 SUSPECTED SUICIDE 1 0.0002
516 OFF LABEL USE 185 0.0002
517 POISONING DELIBERATE 2 0.0002
518 BLOOD PRESSURE DECREASED 14 0.0002
519 HAEMATOTOXICITY 2 0.0002
520 PRODUCT USE IN UNAPPROVED INDICATION 52 0.0002
521 MEDICATION RESIDUE PRESENT 1 0.0002
522 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 2 0.0002
523 SUPRAVENTRICULAR TACHYCARDIA 2 0.0002
524 HYPOGLYCAEMIA 10 0.0002
525 INCORRECT DOSAGE ADMINISTERED 1 0.0002
526 LIVER INJURY 5 0.0002
527 APPLICATION SITE BURN 1 0.0002
528 DIABETIC NEUROPATHY 1 0.0002
529 HYPERHIDROSIS 26 0.0002
530 GASTROINTESTINAL SOUNDS ABNORMAL 1 0.0002
531 HEPATIC ENZYME ABNORMAL 1 0.0002
532 HYPOTONIA 2 0.0002
533 DRUG TOLERANCE 1 0.0002
534 BONE MARROW FAILURE 4 0.0002
535 HYPONATRAEMIA 11 0.0002
536 CACHEXIA 1 0.0002
537 FOETAL DEATH 1 0.0002
538 PERIORBITAL OEDEMA 1 0.0002
539 CONDITION AGGRAVATED 58 0.0002
540 PREMATURE DELIVERY 3 0.0002
541 VIROLOGIC FAILURE 1 0.0002
542 SEPTIC SHOCK 8 0.0002
543 HYPERKERATOSIS 1 0.0002
544 VENTRICULAR FIBRILLATION 2 0.0002
545 STEVENS-JOHNSON SYNDROME 4 0.0002
546 ACUTE PULMONARY OEDEMA 1 0.0002
547 NEUTROPHILIA 1 0.0002
548 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 3 0.0002
549 LETHARGY 10 0.0002
550 MULTI-ORGAN FAILURE 3 0.0002
551 RENAL FAILURE 23 0.0002
552 SOCIAL AVOIDANT BEHAVIOUR 1 0.0002
553 HYPERVENTILATION 1 0.0002
554 RALES 1 0.0002
555 ELECTROLYTE IMBALANCE 2 0.0002
556 ASCITES 5 0.0002
557 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 1 0.0002
558 NEUROLEPTIC MALIGNANT SYNDROME 2 0.0002
559 RESPIRATORY DISORDER 5 0.0002
560 SQUAMOUS CELL CARCINOMA OF SKIN 1 0.0002
561 INJECTION SITE VESICLES 1 0.0002
562 FOETAL GROWTH RESTRICTION 1 0.0002
563 PLEURAL EFFUSION 10 0.0002
564 ACCIDENTAL OVERDOSE 6 0.0002
565 CARDIOMEGALY 2 0.0002
566 CONCOMITANT DISEASE AGGRAVATED 1 0.0002
567 PIGMENTATION DISORDER 1 0.0002
568 CONJUNCTIVITIS 3 0.0002
569 EXTRAPYRAMIDAL DISORDER 4 0.0002
570 INJECTION SITE DISCOLOURATION 2 0.0002
571 INFUSION SITE SWELLING 1 0.0002
572 BRAIN OEDEMA 2 0.0002
573 DRUG RESISTANCE 4 0.0002
574 NIGHT SWEATS 5 0.0002
575 APPLICATION SITE VESICLES 1 0.0002
576 BLOOD PRESSURE SYSTOLIC INCREASED 3 0.0002
577 MUCOSAL INFLAMMATION 4 0.0002
578 PRODUCT PREPARATION ISSUE 1 0.0002
579 ASPERGILLUS INFECTION 1 0.0002
580 PRODUCT FORMULATION ISSUE 1 0.0002
581 ADVERSE REACTION 2 0.0002
582 LEFT VENTRICULAR DYSFUNCTION 1 0.0001
583 QUALITY OF LIFE DECREASED 2 0.0001
584 BRONCHIECTASIS 1 0.0001
585 ULCER HAEMORRHAGE 1 0.0001
586 PRODUCT LABEL ISSUE 1 0.0001
587 INFARCTION 1 0.0001
588 PERITONITIS 3 0.0001
589 LYMPHOEDEMA 1 0.0001
590 LARGE INTESTINE POLYP 1 0.0001
591 THERMAL BURN 1 0.0001
592 LIVER FUNCTION TEST INCREASED 3 0.0001
593 GRAFT VERSUS HOST DISEASE 1 0.0001
594 TONGUE DISORDER 1 0.0001
595 PREMATURE BABY 4 0.0001
596 ECONOMIC PROBLEM 2 0.0001
597 RENAL IMPAIRMENT 11 0.0001
598 CONCUSSION 1 0.0001
599 SOMNOLENCE 26 0.0001
600 DELUSION 2 0.0001
601 HYPOALBUMINAEMIA 1 0.0001
602 THERAPY PARTIAL RESPONDER 2 0.0001
603 PULMONARY HAEMORRHAGE 1 0.0001
604 BRAIN FOG 2 0.0001
605 PANCYTOPENIA 7 0.0001
606 THROMBOCYTOPENIA 14 0.0001
607 MENTAL IMPAIRMENT 3 0.0001
608 NEURALGIA 3 0.0001
609 POLYURIA 1 0.0001
610 ABNORMAL FAECES 1 0.0001
611 DRUG LEVEL INCREASED 2 0.0001
612 EMBOLISM 1 0.0001
613 COMPLETED SUICIDE 10 0.0001
614 LEUKOPENIA 6 0.0001
615 LIVE BIRTH 1 0.0001
616 CANDIDA INFECTION 2 0.0001
617 ANURIA 1 0.0001
618 NEUROPATHY PERIPHERAL 11 0.0001
619 CARDIAC MURMUR 1 0.0001
620 ANHEDONIA 3 0.0001
621 PANCREATITIS 6 0.0001
622 COLD SWEAT 2 0.0001
623 RESPIRATORY RATE INCREASED 1 0.0001
624 WRONG DRUG ADMINISTERED 1 0.0001
625 MYOSITIS 1 0.0001
626 LOSS OF LIBIDO 1 0.0001
627 GASTROINTESTINAL CARCINOMA 1 0.0001
628 SKIN LESION 3 0.0001
629 PNEUMONIA BACTERIAL 1 0.0001
630 TREATMENT FAILURE 9 0.0001
631 NERVE COMPRESSION 1 0.0001
632 PERSONALITY CHANGE 1 0.0001
633 SEPSIS 12 0.0001
634 MIDDLE INSOMNIA 2 0.0001
635 FLANK PAIN 1 0.0001
636 LACERATION 1 0.0001
637 DYSARTHRIA 4 0.0001
638 RECALLED PRODUCT ADMINISTERED 1 0.0001
639 AFFECT LABILITY 1 0.0001
640 HYPERTENSION 22 0.0001
641 ATELECTASIS 1 0.0001
642 DYSTONIA 2 0.0001
643 INTENTIONAL PRODUCT MISUSE 9 0.0001
644 THROMBOTIC MICROANGIOPATHY 1 0.0001
645 KIDNEY INFECTION 2 0.0001
646 THERAPY CHANGE 1 0.0001
647 DISABILITY 2 0.0001
648 BLADDER DISORDER 1 0.0001
649 CYTOKINE RELEASE SYNDROME 2 0.0001
650 PNEUMOCYSTIS JIROVECII PNEUMONIA 1 0.0001
651 CELLULITIS 5 0.0001
652 PRODUCT ADMINISTRATION ERROR 2 0.0001
653 DRY THROAT 1 0.0001
654 TOOTH ABSCESS 1 0.0001
655 NEUTROPHIL COUNT INCREASED 1 0.0001
656 HAEMOGLOBIN DECREASED 10 0.0001
657 INFLAMMATION 5 0.0001
658 HYPERBILIRUBINAEMIA 1 0.0001
659 VENTRICULAR EXTRASYSTOLES 1 0.0001
660 TENDERNESS 1 0.0001
661 CARDIO-RESPIRATORY ARREST 4 0.0001
662 INCONTINENCE 1 0.0001
663 SUDDEN DEATH 1 0.0001
664 HYPOTHYROIDISM 3 0.0001
665 BREAST PAIN 1 0.0001
666 MOVEMENT DISORDER 3 0.0001
667 POOR QUALITY SLEEP 2 0.0001
668 HOT FLUSH 7 0.0001
669 DEEP VEIN THROMBOSIS 6 0.0001
670 BIPOLAR DISORDER 1 0.0001
671 SKIN LACERATION 1 0.0001
672 PRODUCT PRESCRIBING ISSUE 2 0.0001
673 TREATMENT NONCOMPLIANCE 5 0.0001
674 GASTROINTESTINAL PAIN 1 0.0001
675 FUNGAL INFECTION 3 0.0001
676 NERVE INJURY 1 0.0001
677 HYPERTENSIVE CRISIS 1 0.0001
678 MALNUTRITION 1 0.0001
679 SKIN INFECTION 1 0.0001
680 OCULAR DISCOMFORT 1 0.0001
681 REBOUND EFFECT 1 0.0001
682 MITRAL VALVE INCOMPETENCE 1 0.0001
683 SCAB 1 0.0001
684 MADAROSIS 1 0.0001
685 FOETAL EXPOSURE DURING PREGNANCY 7 0.0001
686 COGNITIVE DISORDER 4 0.0001
687 SPLENOMEGALY 1 0.0001
688 TREMOR 14 0.0001
689 BACTERAEMIA 1 0.0001
690 ANAEMIA 16 0.0001
691 LOCALISED INFECTION 2 0.0001
692 C-REACTIVE PROTEIN INCREASED 3 0.0001
693 INJECTION SITE EXTRAVASATION 1 0.0001
694 HYPERCALCAEMIA 1 0.0001
695 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
696 EXPOSURE DURING PREGNANCY 5 0.0001
697 HEPATIC FUNCTION ABNORMAL 3 0.0001
698 DERMATITIS ALLERGIC 1 0.0001
699 HYPOPHAGIA 2 0.0001
700 HEPATITIS 2 0.0001
701 ANOREXIA 1 0.0001
702 PLATELET COUNT INCREASED 1 0.0001
703 NODULE 1 0.0001
704 SEDATION 2 0.0001
705 PULMONARY CONGESTION 1 0.0001
706 CARDIAC FAILURE 6 0.0001
707 EXTRA DOSE ADMINISTERED 3 0.0001
708 ANXIETY 21 0.0001
709 BLINDNESS 3 0.0001
710 IMPAIRED GASTRIC EMPTYING 1 0.0001
711 ACUTE HEPATIC FAILURE 1 0.0001
712 VISION BLURRED 10 0.0001
713 DRUG ABUSE 6 0.0001
714 GASTROINTESTINAL HAEMORRHAGE 6 0.0001
715 NECK PAIN 4 0.0001
716 DEVICE OCCLUSION 1 0.0001
717 SKIN REACTION 1 0.0001
718 RENAL FAILURE ACUTE 3 0.0001
719 SEASONAL ALLERGY 1 0.0001
720 PRODUCT DOSE OMISSION IN ERROR 2 0.0001
721 HEPATOCELLULAR INJURY 1 0.0001
722 DIALYSIS 1 0.0001
723 BRONCHOSPASM 1 0.0001
724 PRODUCT USE ISSUE 13 0.0001
725 INFECTION 10 0.0001
726 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
727 APATHY 1 0.0001
728 ACUTE MYOCARDIAL INFARCTION 2 0.0001
729 CARDIOMYOPATHY 1 0.0001
730 URINARY INCONTINENCE 2 0.0001
731 SKIN HAEMORRHAGE 1 0.0001
732 RENAL INJURY 2 0.0001
733 THERAPEUTIC RESPONSE UNEXPECTED 3 0.0001
734 PYREXIA 23 0.0001
735 STOMATITIS 4 0.0001
736 NEPHROLITHIASIS 3 0.0001
737 DEVICE RELATED INFECTION 1 0.0001
738 PNEUMONIA 21 0.0001
739 LYMPHOMA 1 0.0001
740 MUSCULOSKELETAL CHEST PAIN 1 0.0001
741 TENDONITIS 1 0.0001
742 DISEASE RECURRENCE 3 0.0001
743 PNEUMOTHORAX 1 0.0001
744 ATRIAL FIBRILLATION 6 0.0001
745 EYE DISORDER 2 0.0001
746 GENERAL PHYSICAL HEALTH DETERIORATION 7 0.0001
747 FEBRILE NEUTROPENIA 4 0.0001
748 VISUAL ACUITY REDUCED 2 0.0001
749 SKIN EXFOLIATION 5 0.0001
750 FLUSHING 6 0.0001
751 PARANOIA 1 0.0001
752 NIGHTMARE 2 0.0001
753 LOCAL SWELLING 1 0.0001
754 RASH MACULAR 2 0.0001
755 INJURY 4 0.0001
756 LYMPHOCYTE COUNT DECREASED 1 0.0001
757 TOOTHACHE 1 0.0001
758 URTICARIA 9 0.0001
759 BACTERIAL INFECTION 1 0.0001
760 BLISTER 3 0.0001
761 HEPATIC CIRRHOSIS 1 0.0001
762 UNEVALUABLE EVENT 4 0.0001
763 COLITIS 2 0.0001
764 PROTEINURIA 1 0.0001
765 NEUTROPENIA 7 0.0001
766 SKIN FISSURES 1 0.0001
767 NASAL CONGESTION 3 0.0001
768 BLOOD PRESSURE ABNORMAL 1 0.0001
769 FULL BLOOD COUNT DECREASED 1 0.0000
770 THERAPEUTIC RESPONSE DECREASED 3 0.0000
771 PRODUCT PREPARATION ERROR 1 0.0000
772 POLLAKIURIA 2 0.0000
773 DERMATITIS 1 0.0000
774 HALLUCINATION, VISUAL 1 0.0000
775 HYPOACUSIS 2 0.0000
776 MENTAL DISORDER 2 0.0000
777 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
778 MELAENA 1 0.0000
779 INFUSION RELATED REACTION 3 0.0000
780 TRANSAMINASES INCREASED 1 0.0000
781 PANCREATITIS ACUTE 1 0.0000
782 HEART RATE IRREGULAR 1 0.0000
783 RENAL DISORDER 2 0.0000
784 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1 0.0000
785 CHILLS 5 0.0000
786 VOMITING 20 0.0000
787 DISEASE PROGRESSION 5 0.0000
788 CEREBROVASCULAR ACCIDENT 7 0.0000
789 EMOTIONAL DISTRESS 5 0.0000
790 PRESYNCOPE 1 0.0000
791 OSTEONECROSIS OF JAW 1 0.0000
792 HEART RATE INCREASED 4 0.0000
793 DRY EYE 2 0.0000
794 SYNCOPE 4 0.0000
795 AGGRESSION 2 0.0000
796 PRODUCT COMPLAINT 1 0.0000
797 CARDIOVASCULAR DISORDER 1 0.0000
798 FLUID RETENTION 2 0.0000
799 BLOOD PRESSURE INCREASED 6 0.0000
800 LOSS OF CONSCIOUSNESS 5 0.0000
801 ERECTILE DYSFUNCTION 1 0.0000
802 SKIN ULCER 1 0.0000
803 HAEMATOMA 1 0.0000
804 EXPOSURE VIA SKIN CONTACT 1 0.0000
805 JAUNDICE 1 0.0000
806 DISTURBANCE IN ATTENTION 2 0.0000
807 DRY MOUTH 3 0.0000
808 THROAT TIGHTNESS 1 0.0000
809 MEDICATION ERROR 2 0.0000
810 DEMENTIA 1 0.0000
811 TARDIVE DYSKINESIA 1 0.0000
812 INTENTIONAL DOSE OMISSION 1 0.0000
813 RED BLOOD CELL COUNT DECREASED 1 0.0000
814 CONVULSION 2 0.0000
815 ASTHENIA 13 0.0000
816 ABDOMINAL PAIN 8 0.0000
817 LIVER FUNCTION TEST ABNORMAL 1 0.0000
818 INTENTIONAL PRODUCT USE ISSUE 3 0.0000
819 WHEEZING 2 0.0000
820 MATERNAL EXPOSURE DURING PREGNANCY 3 0.0000
821 FEELING ABNORMAL 8 0.0000
822 BLOOD POTASSIUM DECREASED 1 0.0000
823 LACRIMATION INCREASED 1 0.0000
824 CORONARY ARTERY DISEASE 1 0.0000
825 ILL-DEFINED DISORDER 2 0.0000
826 NAUSEA 26 0.0000
827 VERTIGO 2 0.0000
828 DISCOMFORT 2 0.0000
829 EPILEPSY 1 0.0000
830 MUSCLE SPASMS 6 0.0000
831 FEELING HOT 2 0.0000
832 INJECTION SITE RASH 1 0.0000
833 NASOPHARYNGITIS 6 0.0000
834 LIMB DISCOMFORT 1 0.0000
835 MOOD SWINGS 1 0.0000
836 IMPAIRED HEALING 1 0.0000
837 STAPHYLOCOCCAL INFECTION 1 0.0000
838 DIZZINESS 15 0.0000
839 VIRAL INFECTION 1 0.0000
840 URINARY RETENTION 1 0.0000
841 GAIT INABILITY 1 0.0000
842 ANGER 1 0.0000
843 PRODUCT QUALITY ISSUE 4 0.0000
844 MALIGNANT NEOPLASM PROGRESSION 3 0.0000
845 ACCIDENTAL EXPOSURE TO PRODUCT 3 0.0000
846 INJECTION SITE REACTION 2 0.0000
847 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
848 PLATELET COUNT DECREASED 3 0.0000
849 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
850 RASH 12 0.0000
851 DYSURIA 1 0.0000
852 HEADACHE 17 0.0000
853 FATIGUE 21 0.0000
854 HYPERSENSITIVITY 5 0.0000
855 DYSGEUSIA 2 0.0000
856 EYE SWELLING 1 0.0000
857 HALLUCINATION 2 0.0000
858 INTESTINAL OBSTRUCTION 1 0.0000
859 PARAESTHESIA 4 0.0000
860 CARDIAC FAILURE CONGESTIVE 2 0.0000
861 ERYTHEMA 5 0.0000
862 OSTEOPOROSIS 1 0.0000
863 VISUAL IMPAIRMENT 3 0.0000
864 ABDOMINAL DISCOMFORT 4 0.0000
865 MYALGIA 4 0.0000
866 URINARY TRACT INFECTION 4 0.0000
867 DEVICE LEAKAGE 1 0.0000
868 MUSCULOSKELETAL STIFFNESS 2 0.0000
869 ANGIOEDEMA 1 0.0000
870 LIVER DISORDER 1 0.0000
871 GASTROINTESTINAL DISORDER 2 0.0000
872 INCORRECT DOSE ADMINISTERED 5 0.0000
873 SUICIDAL IDEATION 2 0.0000
874 TINNITUS 1 0.0000
875 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
876 OROPHARYNGEAL PAIN 2 0.0000
877 CARDIAC DISORDER 2 0.0000
878 BLOOD GLUCOSE INCREASED 4 0.0000
879 DYSPNOEA 12 0.0000
880 ARRHYTHMIA 1 0.0000
881 OCULAR HYPERAEMIA 1 0.0000
882 DYSPHAGIA 2 0.0000
883 PRODUCTIVE COUGH 1 0.0000
884 RASH ERYTHEMATOUS 1 0.0000
885 MULTIPLE SCLEROSIS 1 0.0000
886 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
887 PRURITUS 8 0.0000
888 LUNG DISORDER 1 0.0000
889 ILLNESS 2 0.0000
890 ABDOMINAL DISTENSION 2 0.0000
891 MUSCULOSKELETAL PAIN 1 0.0000
892 DERMATITIS ATOPIC 1 0.0000
893 DEPRESSED MOOD 1 0.0000
894 INSOMNIA 5 0.0000
895 DEATH 16 0.0000
896 DRUG EFFECT DECREASED 1 0.0000
897 OEDEMA 1 0.0000
898 ARTHROPATHY 1 0.0000
899 INFLUENZA 2 0.0000
900 EYE PAIN 1 0.0000
901 FLATULENCE 1 0.0000
902 HERPES ZOSTER 1 0.0000
903 EYE IRRITATION 1 0.0000
904 COVID-19 3 0.0000
905 PALPITATIONS 2 0.0000
906 BONE PAIN 1 0.0000
907 CATARACT 1 0.0000
908 IRRITABILITY 1 0.0000
909 JOINT SWELLING 2 0.0000
910 PAIN 10 0.0000
911 INJECTION SITE ERYTHEMA 2 0.0000
912 RHINORRHOEA 1 0.0000
913 SWELLING FACE 1 0.0000
914 HEPATIC ENZYME INCREASED 1 0.0000
915 BURNING SENSATION 1 0.0000
916 THERAPY INTERRUPTED 1 0.0000
917 UNDERDOSE 1 0.0000
918 PRODUCT DOSE OMISSION ISSUE 4 0.0000
919 WEIGHT INCREASED 3 0.0000
920 EPISTAXIS 1 0.0000
921 INJECTION SITE HAEMORRHAGE 1 0.0000
922 THROMBOSIS 1 0.0000
923 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
924 DIARRHOEA 8 0.0000
925 ARTHRALGIA 5 0.0000
926 MYOCARDIAL INFARCTION 2 0.0000
927 DEVICE ISSUE 1 0.0000
928 ADVERSE DRUG REACTION 1 0.0000
929 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2 0.0000
930 NO ADVERSE EVENT 2 0.0000
931 ADVERSE EVENT 1 0.0000
932 CHEST PAIN 2 0.0000
933 COUGH 3 0.0000
934 PULMONARY EMBOLISM 1 0.0000
935 MIGRAINE 1 0.0000
936 GAIT DISTURBANCE 2 0.0000
937 CONTUSION 1 0.0000
938 PAIN IN EXTREMITY 3 0.0000
939 DYSPEPSIA 1 0.0000
940 INJECTION SITE PAIN 3 0.0000
941 CHEST DISCOMFORT 1 0.0000
942 SINUSITIS 1 0.0000
943 HAEMORRHAGE 1 0.0000
944 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
945 MALAISE 4 0.0000
946 DEPRESSION 2 0.0000
947 DECREASED APPETITE 2 0.0000
948 BACK PAIN 2 0.0000
949 OEDEMA PERIPHERAL 1 0.0000
950 DEHYDRATION 1 0.0000
951 DRY SKIN 1 0.0000
952 HYPOAESTHESIA 1 0.0000
953 PERIPHERAL SWELLING 1 0.0000
954 FALL 2 0.0000
955 ABDOMINAL PAIN UPPER 1 0.0000
956 CONSTIPATION 1 0.0000
957 WEIGHT DECREASED 1 0.0000